Firstwordpharma
Published September 8, 2026 · Updated September 9, 2026
Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B ...
Read the full story at Firstwordpharma
Clearmind is a clinical-stage neuroplastogens pharmaceutical biotech company focused on the discovery and development of non- hallucinogenic.
Surfaced by this Google Alert
- Psychedelic biotech
